Brief: ALK-Abello Q1 Tablet Sales Increased Overall By 1% To DKK 581 Mln

Alk-Abello A/S

09/05/2023 06:30

May 9 (Reuters) - ALK-Abello A/S  ALKb.CO :
    * THREE-MONTH INTERIM REPORT (Q1) 2023
    * FULL-YEAR REVENUE AND EARNINGS OUTLOOK REMAINS UNCHANGED
    * COMBINED SCIT AND SLIT-DROPS SALES EXCEEDED EXPECTATIONS
    * Q1 TABLET SALES WERE AROUND DKK 35 MILLION LOWER THAN
PLANNED ON
SLOWER GROWTH IN NEW PATIENT INITIATIONS
    * EBIT INCREASED ON SALES GROWTH, MARGIN IMPROVEMENTS AND
EFFICIENCIES, PARTLY OFFSET BY HIGHER SALES AND MARKETING
EXPENSES
    * Q1 TABLET SALES INCREASED OVERALL BY 1% TO DKK 581 MILLION
(583)
    * Q1 SALES IN EUROPE WERE LOWER THAN EXPECTED FOLLOWING
INITIATION
OF ONLY ABOUT 95% OF EXPECTED NUMBER OF NEW PATIENTS
    * INITIATIVES HAVE BEEN LAUNCHED TO RESTORE MOMENTUM IN
GERMANY,
NORDIC MARKETS
    * SALES OF OTHER PRODUCTS WERE UP BY 14% TO DKK 143 MILLION
(123)
    * TOP-LINE RESULTS FROM PAEDIATRIC MT-12 PHASE III TRIAL
WITH
HOUSE DUST MITE TABLET ARE NOW EXPECTED IN MID-2023

Source text for Eikon:  ID:nGNE57wxWz 
Further company coverage:  ALKb.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))